Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced fourth-quarter 2024 monetary outcomes, reporting a double-digit dip in adjusted earnings and a rise in revenues.
The corporate reported worldwide web revenues of $15.1 billion for the December quarter, up 6% from the corresponding interval of 2023. The principle working segments registered development.
Web earnings, adjusted for particular objects, declined to $2.16 per share in This autumn from $2.79 per share within the year-ago quarter. On a reported foundation, it was a web lack of $22 million or $0.02 per share within the fourth quarter, in comparison with a revenue of $822 million or $0.46 per share final 12 months.
